Professional Summary
Professional Overview
Nathan Fuller is a highly experienced Senior Director of Medicinal Chemistry with a proven track record of driving innovation and advancing drug development programs in the pharmaceutical industry. With a strong focus on medicinal chemistry, he brings extensive expertise in lead optimization, drug discovery, and strategic portfolio management.
Experience Summary
Current Role
As the Senior Director of Medicinal Chemistry at Rectify Pharma, Nathan leads a team of talented chemists in the discovery and development of novel therapeutic candidates. In this role, he is responsible for overseeing the design, synthesis, and optimization of small molecule drug candidates, as well as collaborating with cross-functional teams to ensure the successful progression of projects through the drug development pipeline.
Career Progression
Prior to his current position, Nathan served as the Senior Director and Head of Chemistry at Atlas Newco, where he played a pivotal role in restructuring the company's chemistry operations and driving the advancement of multiple drug candidates. Before that, he held the role of Director of Chemistry at Alkermes, where he led a team of scientists in the development of small molecule therapeutics for central nervous system (CNS) disorders.
Nathan's earlier experience includes senior-level positions at Rodin Therapeutics and AstraZeneca, where he demonstrated his expertise in medicinal chemistry, project management, and cross-functional collaboration. He has a proven track record of successfully advancing drug candidates from early discovery through clinical development, with several compounds reaching clinical trials under his leadership.
Academic Background
Nathan holds a Ph.D. in Organic Chemistry from The University of Texas at Austin, where he conducted postdoctoral research focusing on the synthesis and evaluation of novel small molecule inhibitors. His academic achievements include several peer-reviewed publications and presentations at industry conferences.
Areas of Expertise
- Medicinal chemistry
- Lead optimization and drug discovery
- Synthetic organic chemistry
- Preclinical drug development
- Project management and cross-functional collaboration
- Strategic portfolio management
Professional Impact
Throughout his career, Nathan has made significant contributions to the pharmaceutical industry, including the development of several clinical-stage drug candidates. His expertise in medicinal chemistry and proven ability to drive drug discovery programs have been instrumental in advancing novel treatments for a variety of therapeutic areas, including oncology, neurology, and metabolic disorders.
Conclusion
With his extensive experience, strong technical expertise, and proven leadership abilities, Nathan Fuller is a valuable asset to the pharmaceutical industry. As the Senior Director of Medicinal Chemistry at Rectify Pharma, he is well-positioned to continue making meaningful contributions to the development of innovative therapies that address unmet medical needs.
